CN105558788A - 一种食用可治糖尿病、高血压的发糕及制备方法 - Google Patents
一种食用可治糖尿病、高血压的发糕及制备方法 Download PDFInfo
- Publication number
- CN105558788A CN105558788A CN201510917494.4A CN201510917494A CN105558788A CN 105558788 A CN105558788 A CN 105558788A CN 201510917494 A CN201510917494 A CN 201510917494A CN 105558788 A CN105558788 A CN 105558788A
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- steamed sponge
- quality
- volumetric concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 23
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000000284 extract Substances 0.000 claims abstract description 95
- 240000008042 Zea mays Species 0.000 claims abstract description 32
- 241000005787 Cistanche Species 0.000 claims abstract description 27
- 244000197580 Poria cocos Species 0.000 claims abstract description 25
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 25
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims abstract description 24
- 241000222336 Ganoderma Species 0.000 claims abstract description 16
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 16
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 13
- 235000005822 corn Nutrition 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 239000009636 Huang Qi Substances 0.000 claims abstract description 7
- 240000008790 Musa x paradisiaca Species 0.000 claims abstract 9
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 25
- 240000007164 Salvia officinalis Species 0.000 claims description 23
- 235000013399 edible fruits Nutrition 0.000 claims description 22
- 240000002948 Ophiopogon intermedius Species 0.000 claims description 19
- 230000001631 hypertensive effect Effects 0.000 claims description 19
- 235000001188 Peltandra virginica Nutrition 0.000 claims description 17
- 235000017276 Salvia Nutrition 0.000 claims description 17
- 235000009467 Carica papaya Nutrition 0.000 claims description 16
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims description 16
- 235000007244 Zea mays Nutrition 0.000 claims description 16
- 229940107666 astragalus root Drugs 0.000 claims description 16
- 229940089639 cornsilk Drugs 0.000 claims description 16
- 239000000047 product Substances 0.000 claims description 16
- 239000001231 zea mays silk Substances 0.000 claims description 16
- 235000006264 Asimina triloba Nutrition 0.000 claims description 15
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 15
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 15
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 15
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 15
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 15
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 15
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 15
- 240000000171 Crataegus monogyna Species 0.000 claims description 15
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 15
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 15
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 15
- 241000830535 Ligustrum lucidum Species 0.000 claims description 15
- 244000241838 Lycium barbarum Species 0.000 claims description 15
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 14
- 238000010438 heat treatment Methods 0.000 claims description 14
- 238000010992 reflux Methods 0.000 claims description 14
- 238000004506 ultrasonic cleaning Methods 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- 239000011780 sodium chloride Substances 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 235000015203 fruit juice Nutrition 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 6
- 235000005412 red sage Nutrition 0.000 claims description 6
- 235000021307 Triticum Nutrition 0.000 claims description 3
- 244000098338 Triticum aestivum Species 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 230000006837 decompression Effects 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 235000013312 flour Nutrition 0.000 claims description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 238000004064 recycling Methods 0.000 claims description 3
- 238000005057 refrigeration Methods 0.000 claims description 3
- 239000002893 slag Substances 0.000 claims description 3
- 244000189799 Asimina triloba Species 0.000 claims 4
- 230000000694 effects Effects 0.000 abstract description 16
- 239000008280 blood Substances 0.000 abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 3
- 230000004151 fermentation Effects 0.000 abstract description 3
- 239000008103 glucose Substances 0.000 abstract description 3
- 241000233866 Fungi Species 0.000 abstract description 2
- 240000001307 Myosotis scorpioides Species 0.000 abstract description 2
- 238000000855 fermentation Methods 0.000 abstract description 2
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 240000005561 Musa balbisiana Species 0.000 description 15
- 239000000796 flavoring agent Substances 0.000 description 14
- 235000019634 flavors Nutrition 0.000 description 14
- 230000006870 function Effects 0.000 description 13
- 240000006432 Carica papaya Species 0.000 description 12
- 235000009508 confectionery Nutrition 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 12
- 210000003734 kidney Anatomy 0.000 description 11
- 241000196324 Embryophyta Species 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 8
- PAFLSMZLRSPALU-MRVPVSSYSA-N (2R)-3-(3,4-dihydroxyphenyl)lactic acid Chemical compound OC(=O)[C@H](O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-MRVPVSSYSA-N 0.000 description 5
- PAFLSMZLRSPALU-QMMMGPOBSA-N Danshensu Natural products OC(=O)[C@@H](O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-QMMMGPOBSA-N 0.000 description 5
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 5
- PAFLSMZLRSPALU-UHFFFAOYSA-N Salvianic acid A Natural products OC(=O)C(O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-UHFFFAOYSA-N 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- HYXITZLLTYIPOF-UHFFFAOYSA-N Tanshinone II Natural products O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1C(C)=CO2 HYXITZLLTYIPOF-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- QMNWISYXSJWHRY-YLNUDOOFSA-N astragaloside IV Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)[C@H]4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)C[C@H]3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-YLNUDOOFSA-N 0.000 description 4
- QMNWISYXSJWHRY-BCBPIKMJSA-N astragaloside IV Natural products CC(C)(O)[C@@H]1CC[C@@](C)(O1)[C@H]2[C@@H](O)C[C@@]3(C)[C@@H]4C[C@H](O[C@@H]5O[C@H](CO)[C@H](O)[C@@H](O)[C@H]5O)[C@H]6C(C)(C)[C@H](CC[C@@]67C[C@@]47CC[C@]23C)O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O QMNWISYXSJWHRY-BCBPIKMJSA-N 0.000 description 4
- 235000006533 astragalus Nutrition 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 210000004351 coronary vessel Anatomy 0.000 description 4
- PFKIBRPYVNVMRU-UHFFFAOYSA-N cyclosieversioside F Natural products CC(C)(O)C1COC(C)(C1)C2C(O)CC3(C)C4CC(OC5OC(CO)C(O)C(O)C5O)C6C(C)(C)C(CCC67CC47CCC23C)OC8OCC(O)C(O)C8O PFKIBRPYVNVMRU-UHFFFAOYSA-N 0.000 description 4
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000002107 myocardial effect Effects 0.000 description 4
- 239000001103 potassium chloride Substances 0.000 description 4
- 235000011164 potassium chloride Nutrition 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- AZEZEAABTDXEHR-UHFFFAOYSA-M sodium;1,6,6-trimethyl-10,11-dioxo-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-2-sulfonate Chemical compound [Na+].C12=CC=C(C(CCC3)(C)C)C3=C2C(=O)C(=O)C2=C1OC(S([O-])(=O)=O)=C2C AZEZEAABTDXEHR-UHFFFAOYSA-M 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N tanshinone IIA Natural products C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 4
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241001061264 Astragalus Species 0.000 description 3
- GVKKJJOMQCNPGB-JTQLQIEISA-N Cryptotanshinone Chemical compound O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1[C@@H](C)CO2 GVKKJJOMQCNPGB-JTQLQIEISA-N 0.000 description 3
- GVKKJJOMQCNPGB-UHFFFAOYSA-N Cryptotanshinone Natural products O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1C(C)CO2 GVKKJJOMQCNPGB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 240000008397 Ganoderma lucidum Species 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 240000004371 Panax ginseng Species 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 235000009973 maize Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000004233 talus Anatomy 0.000 description 3
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 2
- UGMQOYZVOPASJF-OXUZYLMNSA-N (2r)-2-[(3s,5r,10s,13r,14r,17r)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-17-yl]-6-methyl-5-methylideneheptanoic acid Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CCC1=C2CC[C@]2(C)[C@@H]([C@@H](CCC(=C)C(C)C)C(O)=O)CC[C@]21C UGMQOYZVOPASJF-OXUZYLMNSA-N 0.000 description 2
- IBGBGRVKPALMCQ-UHFFFAOYSA-N 3,4-dihydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1O IBGBGRVKPALMCQ-UHFFFAOYSA-N 0.000 description 2
- HOMSOWZTBJWNHP-UHFFFAOYSA-N 5-chlorothiadiazole Chemical compound ClC1=CN=NS1 HOMSOWZTBJWNHP-UHFFFAOYSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 240000000425 Chaenomeles speciosa Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- UGMQOYZVOPASJF-UHFFFAOYSA-N Eburicoinsaeure Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)CCC21C UGMQOYZVOPASJF-UHFFFAOYSA-N 0.000 description 2
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 241000222341 Polyporaceae Species 0.000 description 2
- 235000003434 Sesamum indicum Nutrition 0.000 description 2
- 244000040738 Sesamum orientale Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 230000003143 atherosclerotic effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229960003638 dopamine Drugs 0.000 description 2
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 229960004502 levodopa Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- VDYCLYGKCGVBHN-UHFFFAOYSA-N pachymaic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)C(O)CC21C VDYCLYGKCGVBHN-UHFFFAOYSA-N 0.000 description 2
- SRDNLMOBFKJOSD-UHFFFAOYSA-N pachymic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C(O)=O)C(O)CC21C SRDNLMOBFKJOSD-UHFFFAOYSA-N 0.000 description 2
- 229940098695 palmitic acid Drugs 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- -1 triterpene carboxylic acid Chemical class 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- XADJANKGURNTIA-YEXRKOARSA-N (2r)-2-[(3s,5r,10s,13r,14r,16r,17r)-3,16-dihydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-17-yl]-6-methyl-5-methylideneheptanoic acid Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CCC1=C2CC[C@]2(C)[C@@H]([C@@H](CCC(=C)C(C)C)C(O)=O)[C@H](O)C[C@]21C XADJANKGURNTIA-YEXRKOARSA-N 0.000 description 1
- XDUXBBDRILEIEZ-LJQANCHMSA-N (6s)-6-(hydroxymethyl)-1,6-dimethyl-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCC[C@](C)(CO)C3=CC=C2C2=C1C(C)=CO2 XDUXBBDRILEIEZ-LJQANCHMSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 description 1
- 102000016912 Aldehyde Reductase Human genes 0.000 description 1
- 108010053754 Aldehyde reductase Proteins 0.000 description 1
- 235000013479 Amaranthus retroflexus Nutrition 0.000 description 1
- 241000045403 Astragalus propinquus Species 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 240000005674 Ceanothus americanus Species 0.000 description 1
- 235000014224 Ceanothus americanus Nutrition 0.000 description 1
- 235000001904 Ceanothus herbaceus Nutrition 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 235000005078 Chaenomeles speciosa Nutrition 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 241000221751 Claviceps purpurea Species 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 241000142975 Cornaceae Species 0.000 description 1
- 244000160089 Crataegus cuneata Species 0.000 description 1
- 235000008440 Crataegus cuneata Nutrition 0.000 description 1
- 235000014283 Crataegus pinnatifida var major Nutrition 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- GZZPOFFXKUVNSW-UHFFFAOYSA-N Dodecenoic acid Natural products OC(=O)CCCCCCCCCC=C GZZPOFFXKUVNSW-UHFFFAOYSA-N 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 241000130660 Hepialidae Species 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 235000003332 Ilex aquifolium Nutrition 0.000 description 1
- 235000002296 Ilex sandwicensis Nutrition 0.000 description 1
- 235000002294 Ilex volkensiana Nutrition 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 244000208060 Lawsonia inermis Species 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 241000234295 Musa Species 0.000 description 1
- 235000003805 Musa ABB Group Nutrition 0.000 description 1
- 241000234615 Musaceae Species 0.000 description 1
- XRFKFDNVAJQFLJ-UHFFFAOYSA-N N1C(CC1)C(=O)O.N1C(CC1)C(=O)O Chemical compound N1C(CC1)C(=O)O.N1C(CC1)C(=O)O XRFKFDNVAJQFLJ-UHFFFAOYSA-N 0.000 description 1
- 241000207834 Oleaceae Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 208000018262 Peripheral vascular disease Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 235000015266 Plantago major Nutrition 0.000 description 1
- 241000222383 Polyporales Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 108010072866 Prostate-Specific Antigen Proteins 0.000 description 1
- 102100038358 Prostate-specific antigen Human genes 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 206010038468 Renal hypertrophy Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- XDUXBBDRILEIEZ-UHFFFAOYSA-N Tanshinone IIB Natural products O=C1C(=O)C2=C3CCCC(C)(CO)C3=CC=C2C2=C1C(C)=CO2 XDUXBBDRILEIEZ-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- XADJANKGURNTIA-UHFFFAOYSA-N Tumulosic acid Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)C(O)CC21C XADJANKGURNTIA-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 102100023038 WD and tetratricopeptide repeats protein 1 Human genes 0.000 description 1
- 241001619454 Wolfiporia Species 0.000 description 1
- 241001619444 Wolfiporia cocos Species 0.000 description 1
- 241001251949 Xanthium sibiricum Species 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229930182482 anthraquinone glycoside Natural products 0.000 description 1
- 229940098421 anthraquinone glycoside Drugs 0.000 description 1
- 150000008139 anthraquinone glycosides Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 210000002565 arteriole Anatomy 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 229940047169 astragalus root extract Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 229940097217 cardiac glycoside Drugs 0.000 description 1
- 239000002368 cardiac glycoside Substances 0.000 description 1
- 230000001925 catabolic effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000035603 choleresis Effects 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 150000005205 dihydroxybenzenes Chemical class 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 201000008627 kidney hypertrophy Diseases 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 229940033355 lauric acid Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 229940118199 levulan Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000003584 mesangial cell Anatomy 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003680 myocardial damage Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 230000001662 opsonic effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- LPMXVESGRSUGHW-HBYQJFLCSA-N ouabain Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)C[C@@H](O)[C@@H]3[C@@]2(CO)[C@H](O)C1 LPMXVESGRSUGHW-HBYQJFLCSA-N 0.000 description 1
- 108010071584 oxidized low density lipoprotein Proteins 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 229930184064 pinicolic acid Natural products 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 229960003371 protocatechualdehyde Drugs 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种食用可治糖尿病、高血压的发糕及制备方法，所述的该发糕是由下述重量份的原料配制成的：黄芪提取物3~8份、丹参提取物2~6份、茯苓提取物3~8份、玉米须提取物3~8份、灵芝10~20份、女贞子20~40份、麦冬10~20份、玉竹提取物10~20份、冬虫夏草50~80份、山茱萸20~30份、肉苁蓉提取物15~25份、香蕉皮提取物10~20份、木瓜10~20份、枸杞10~20份、山楂10~20份。本发明提供了该产品的配方及其成熟的发酵工艺，科学添加中药提取物具有有效预防治疗糖尿病、高血压患者；食用方便，味道可口，而且能纠正血液流变性异常，降低血糖，是一款高大上的健康保健发糕。
Description
技术领域
本发明隶属于保健食品领域，尤其是提供了一种食用可治糖尿病、高血压的发糕及制备方法。
背景技术
发糕是汉族传统的大米发酵面点，色泽洁白，绵软甜润，粉肉可口，经浸泡、磨浆、调味、发酵、蒸制而成。它具有独特的风味和较高的营养保健功能，尤其适合老年人和儿童食用。是夏秋季节应时小吃，具有独特的风味及较高的营养保健功能。目前市面上食用可治糖尿病、高血压的发糕还没有，本发明的目的就是将中药提取物及水果相结合，科学配伍了一组针对糖尿病、高血压具有治疗效果的组合，加入到发糕中，使得成为一款高端保健发糕食品。
发明内容
本发明的目的在于提供中药提取物为主组合发糕中的一种保健食品，尤其是提供了一种食用可治糖尿病、高血压的发糕及制备方法，来满足上述背景技术中所提的问题。
为了实现上述目的，本发明提供如下技术方案：
本发明的一种食用可治糖尿病、高血压的发糕，它是由下述重量份的原料配制而成的：黄芪提取物3~8份、丹参提取物2~6份、茯苓提取物3~8份、玉米须提取物3~8份、灵芝10~20份、女贞子20~40份、麦冬10~20份、玉竹提取物10~20份、冬虫夏草50~80份、山茱萸20~30份、肉苁蓉提取物15~25份、香蕉皮提取物10~20份、木瓜10~20份、枸杞10~20份、山楂10~20份。
作为本发明进一步的方案：优选了由下述重量份的原料配制成的：黄芪提取物5份、丹参提取物3份、茯苓提取物5份、玉米须提取物5份、灵芝10份、女贞子30份、麦冬10份、玉竹提取物10份、冬虫夏草60份、山茱萸30份、肉苁蓉提取物15份、香蕉皮提取物15份、木瓜15份、枸杞15份、山楂10份。
上述技术方案中，所述黄芪提取物是由下述方法制成：称取黄芪，加入所述黄芪质量3倍的体积浓度为75%的乙醇水溶液，置85kHz的超声波清洗仪器中超声4分钟，再加入所述黄芪质量7倍的体积浓度为75%的乙醇水溶液，常压加热回流3小时，滤过，浓缩提取物。
上述技术方案中，所述丹参提取物是由下述方法制成：称取丹参，加入所述丹参质量3倍的体积浓度为60%的乙醇水溶液，置85kHz的超声波清洗仪器中超声4分钟，再加入所述丹参质量7倍的体积浓度为60%的乙醇水溶液，常压加热回流3小时，滤过，浓缩提取物。
上述技术方案中，所述茯苓提取物是由下述方法制成：称取茯苓，加入所述茯苓质量3倍的体积浓度为60%的乙醇水溶液，置85kHz的超声波清洗仪器中超声4分钟，再加入所述茯苓质量7倍的体积浓度为75%的乙醇水溶液，常压加热回流3小时，滤过，浓缩提取物。
上述技术方案中，所述玉米须提取物是由下述方法制成：称取玉米须，加入所述玉米须质量3倍的体积浓度为60%的乙醇水溶液，置85kHz的超声波清洗仪器中超声4分钟，再加入所述玉米须质量7倍的体积浓度为75%的乙醇水溶液，常压加热回流3小时，滤过，浓缩提取物。
上述技术方案中，所述玉竹提取物是由下述方法制成：称取玉竹，加入所述玉竹质量3倍的体积浓度为60%的乙醇水溶液，置85kHz的超声波清洗仪器中超声4分钟，再加入所述玉竹质量7倍的体积浓度为60%的乙醇水溶液，常压加热回流3小时，滤过，浓缩提取物。
上述技术方案中，所述肉苁蓉提取物是由下述方法制成：称取肉苁蓉，加入所述肉苁蓉质量3倍的体积浓度为65%的乙醇水溶液，置85kHz的超声波清洗仪器中超声4分钟，再加入所述肉苁蓉质量7倍的体积浓度为70%的乙醇水溶液，常压加热回流3小时，滤过，浓缩提取物。
上述技术方案中，所述香蕉皮提取物是由下述方法制成：称取香蕉皮，加入所述香蕉皮质量3倍的体积浓度为60%的乙醇水溶液，置85kHz的超声波清洗仪器中超声4分钟，再加入所述香蕉皮质量7倍的体积浓度为60%的乙醇水溶液，常压加热回流3小时，滤过，浓缩提取物。
本发明还提供上述一种食用可治糖尿病、高血压的发糕的制备方法，本技术领域中通常采用人们熟知的方法包括如下步骤：
1)称取下述各重量份原料：黄芪提取物3~8份、丹参提取物2~6份、茯苓提取物3~8份、玉米须提取物3~8份、灵芝10~20份、女贞子20~40份、麦冬10~20份、玉竹提取物10~20份、冬虫夏草50~80份、山茱萸20~30份、肉苁蓉提取物15~25份、香蕉皮提取物10~20份、木瓜10~20份、枸杞10~20份、山楂10~20份；
2)将上述灵芝、女贞子、麦冬、冬虫夏草、山茱萸一起加水煎煮二次，第一次加水6倍量，煎煮2小时，第二次加水4倍量，煎煮1小时，合并提取液，滤过，滤液浓缩至相对密度为1.15～1.20，加乙醇至含醇量为70％，搅拌均匀，冷藏静置，滤过，滤液减压回收乙醇至无醇味并浓缩至稠膏；
3)将木瓜、枸杞、山楂混合经榨汁机搅拌，去渣，取果汁备用；
4)取小麦粉，倒入各重量份的黄芪提取物、丹参提取物、茯苓提取物、玉米须提取物、玉竹提取物、肉苁蓉提取物、香蕉皮提取物、步骤2）所得的稠膏和步骤3）所得的果汁，加入适量水经和面机搅拌，放进发酵箱中，设置25～30℃，第一次醒发60-120分钟后，再用和面机搅拌5～10分钟，挤压面团内的气泡，防止成品形成大的空泡，放入发酵箱，设置温度25～30℃，第二次醒发25-40分钟；最后将发酵好的面团直接倒入预先抹好薄油的模具中，与模具一起覆上保鲜膜，直接隔水蒸30-50分钟，出锅后冷却脱模、包装、出厂，即得。
本发明所使用的原料具有如下特性：
黄芪提取物：【英文名称】：AstragalusRootExtract【CAS】：9005-38-3【植物拉丁名】：Astragalusmembranaceus（Fisch.）Bge.【植物来源】：为豆科植物蒙古黄芪的根提取物。【产品性质】：本品为棕黄色或灰白色粉末。【有效成分】：黄芪甲苷，黄芪多糖【药理作用】：具有增强免疫力，增强能量，抗疲劳，抗突变，保肝，抑制破骨细胞的作用。黄芪多糖具有降血脂，即降低胆固醇和甘油三酯、升高高密度脂蛋白的作用；能够预防和治疗心脑血管疾病，如动脉粥样硬化、冠状动脉病变、周围血管病变以及高脂血症等。黄芪甲苷具有显著降低血糖、糖化血红蛋白和尿蛋白的作用，可降低肾皮质和血清中的AGEs，显示黄芪甲苷具有抗氧化作用，并对醛糖还原酶有抑制作用，还有抑制系膜细胞增生、减轻肾脏肥大的作用。在黄芪甲苷中加入适当辅料，可制成口服制剂，它用于预防和治疗糖尿病肾病
丹参提取物：iza，别名：赤参、紫丹参、亦参、木羊乳、逐马、山参、红根、紫党参、血根参、山红萝卜、山苏子根等。本品为棕红色的粉末；有特殊气味，不具引湿性。本品易溶于三氯甲烷、二氯甲烷，溶解于丙酮，微溶于甲醇、乙醇、乙酸乙酯。丹参酮IIA，丹酚酸B，隐丹参酮：主要有脂溶性非醌色素类化合物，如丹参酮ⅡA、丹参酮ⅡB、隐丹参酮及其异构体。水溶性酚酸类成分如原儿茶醛、丹参素。其中，隐丹参酮是抗菌的有效成分。（1）对冠状动脉作用：治疗冠心病，能改善冠状动脉循环，抑制血栓疾病发生。丹参素具有显著扩张冠状动脉，增加冠脉血流量，降低心肌耗氧量，减慢心率和增加心肌收缩力的作用。（2）对心肌修复作用：丹参素及丹参酮IIA均能显著延长小鼠耐缺氧时间，减轻缺氧引起的心肌损伤，同时，改善心肌收缩力，促进心肌再生。（3）对微循环作用：丹参舒心胶囊能扩张动物微动脉，使毛细管网开放数量增多，加快血液流速、流量，从而改善微循环障碍。（4）对血液流变性作用：丹参素及丹参酮IIA有抑制ADP诱导血小板凝集、抑制血小板TXA2的合成与释放缩血管物质及促进纤维蛋白降解作用。可降低冠心病、脑缺血中风及心肌梗塞病人的全血和血浆粘度，减少红细胞压积，通过抗凝降粘的作用使患者血液流变学指标恢复正常。5）对血脂的作用：丹参素可抑制内源性胆固醇的合成，降低氧化低密度脂蛋白（LDL）的生成，降低中性脂肪，可用于高脂血症引起的动脉粥样硬化。
茯苓提取物：英文名：IndianBuead，Tuckahoe拉丁植物动物矿物名：Wolfiporiacocos(Schw.)Ryv.&Gibn别名：茯菟、茯灵、茯蕶、伏苓、伏菟、松腴、绛晨伏胎、云苓、茯兔、松薯、松木薯、松苓。生物学分类：隶属于非褶菌目Aphyllophorales，多孔菌科Polyporaceae，茯苓属Wolfiporia。性味：甘、淡，平。归经：归心经、肺经、脾经、肾经。主要含β-茯苓聚糖（β-Pachyman）,约占干重的９３％,和三萜类化合物茯苓酸（Pachymicacid）、土牧酸（Tumulosicacid）、三萜羧酸（Triterpenecarboxylicacid）、齿孔酸（Eburioicacid）、松苓酸（Pinicolicacid）等．亦含脂肪酸,如辛酸（Caprylicacid）、十一酸（Undecanoicacid）、月桂酸（Lauricacid）、十二酸（Dodecenoicacid）和棕榈酸（Palmiticacid）．此外,尚含麦角甾醇（Ergosterol）、树胶、甲壳质、蛋白质、脂肪、甾醇、卵磷脂、右旋葡萄糖、腺嘌呤（Adenine）、组胺酸（Histidine）、胆碱（Choline）、β-茯苓聚糖分解酶、脂肪酶、蛋白酶等。功能主治：利水药；渗湿利尿药。
玉米须提取物：别名：玉麦须、玉蜀黍蕊，本品禾本科植物玉蜀黍ZeamaysL.的花柱。性状：精细棕黄色粉末，药用部位：花柱，性味归经：平；甘、淡；归膀胱、肝、胆经；玉米须含维生素K、β－谷甾醇、葡萄糖、有机酸等成分。玉米须全草含大量去甲基肾上腺素（No-radrenaline）和多量钾盐（氯化钾、硝酸钾、硫酸钾等，以K2O计算，鲜草含钾盐1%，干草含钾盐17%）。此外尚含二羟基苯乙胺（Dopamine，多巴胺）、二羟基苯丙氨酸（DOPA）。苹果酸、柠檬酸、谷胺酸、天冬胺酸、丙胺酸及蔗糖、葡萄糖、果糖等。亦含有蛋白质，脂肪，糖，粗纤维，钙，磷，铁，维生素A、B、C等。全草含尚含生物碱、香豆精类、黄酮类、强心甙和蒽醌甙。药理研究证明，玉米须有利尿、降压、促进胆汁分泌，增加学中凝血酶和加速血液凝固等作用。玉米须有防治高血压的作用。一些学者研究发现，玉米中含的钙能降压。β－谷甾醇能够抑制肿瘤的生长，降低前列腺特异抗原PSA的释放水平。玉米须中同样含有大量的镁。镁可以致癌的发展，帮助血管舒张，加强肠壁蠕动，增加胆汁，促进机体排出废物。镁还可防止缺血性心脏病，维持心肌正常功能。
玉竹提取物：玉竹提取物为百合科植物玉竹的根茎，化学成分：根茎含玉竹粘多糖（odoratan）及4种玉竹果聚糖（polygonatum-fructan-O-A，B，C，D），还含吖丁啶-2-羧酸（azetidin-2-carboxylicacid）等。具有养阴润燥、生津止渴的功效，用于主治肺胃阴伤、燥热咳嗽、咽干口渴、内热消渴等症状。
肉苁蓉提取物：肉苁蓉（学名：CistanchedeserticolaMa），别名疆芸、寸芸、苁 蓉、查干告亚（蒙语），属濒危种。肉苁蓉是一种寄生在沙漠树木梭梭根部的寄生植物，从梭梭寄主中吸取养分及水份。素有“沙漠人参”之美誉，具有极高的药用价值，是中国传统的名贵中药材。从20世纪80年代开始，国内外对肉苁蓉的成分进行了大量研究，其中日本起步较早，随着分离提取和检测技术的飞速发展，已分离出多种类型的物质，主要可分为苯乙醇苷类、环烯醚萜类、木脂素类、多糖、十几种氨基酸、多种生物碱等，富含人体所需微量元素，其中苯乙醇总苷是肉苁蓉中主要活性成分，性味：味甘、咸、性温，归经：归肾、大肠经；功能主治：补肾阳，益精血，润肠道。
香蕉皮提取物：【英文】BananaP.E.【提取来源】为芭蕉科植物大蕉和香蕉的果实。拉丁植物动物矿物名：1.MusasapientumL.[MlparadisiacaL.var.sapientum(L.)O.Kuntze]2.MusananaLour；采收和储藏：果实将成熟时采收，鲜用或晒干。【性味】味甘；性寒。【归经】入肺；脾经。【功效】清热；润肺；滑肠；解毒。
灵芝：【别名】灵芝草、菌灵芝、木灵芝【来源】本品为多孔菌科真菌赤芝Ganodermalucidum（Leyss.exFr.）Karst．或紫芝GanodermasinenseZhao，XuetZhang的干燥子实体。【性味】甘，平。【归经】归心、肺、肝、肾经。【功能主治】补气安神，止咳平喘。【摘录】《中国药典》。
女贞子：【别名】爆格蚤、冬青子[河北、江苏、福建、广西、云南]【来源】本品为木犀科植物女贞LigustrumlucidumAit.的干燥成熟果实。【性味】甘、苦，凉。【归经】归肝、肾经。【功能主治】滋补肝肾，明目乌发。
麦冬：【别名】麦门冬、沿阶草【来源】本品为百合科植物麦冬（沿阶草）Ophiopogonjaponicus（Thunb.）Ker-Gawl.的干燥块根。【性味】甘，微苦，微寒。【归经】归心、肺、胃经。【功能主治】养阴生津，润肺清心。
冬虫夏草：【别名】虫草、冬虫草、夏草冬虫，【来源】本品为麦角菌科真菌冬虫夏草菌Cordycepssinensis（Berk.）Sacc.寄生在蝙蝠蛾科昆虫幼虫上的子座及幼虫尸体的复合体。【性味】甘，平。【归经】归肺、肾经。【功能主治】补肺益肾，止血化痰。
山茱萸：【来源】本品为山茱萸科植物山茱萸CornusofficinalisSieb.etZucc.的干燥成熟果肉。【性味】酸、涩，微温。【归经】归肝、肾经。【功能主治】补益肝肾，涩精固脱。
木瓜：【别名】贴梗海棠、铁脚梨、皱皮木瓜、宣木瓜【来源】本品为蔷薇科植物贴梗海棠Chaenomelesspeciosa（Sweet）Nakai的干燥近成熟果实。【性味】酸，温。【归经】归肝、脾经。【功能主治】平肝舒筋，和胃化湿。摘录《中国药典》。
枸杞：【来源】本品为茄科植物宁夏枸杞LyciumbarbarumL.的干燥成熟果实。【性味】甘，平。【归经】归肝、肾经。【功能主治】滋补肝肾，益精明目。
山楂：【来源】本品为蔷薇科植物山里红CrataeguspinnatifidaBge.var.majorN.E.Br.或山楂CrataeguspinnatifidaBge.的干燥成熟果实。【性味】酸、甘、微温【归经】归脾、胃、肝经。【功能主治】消食健胃，行气散瘀。
有益效果
本发明的一种食用可治糖尿病、高血压的发糕，优点在于：
(1)借助人们喜爱吃的发糕，进行技术改良，科学配伍添加中药提取物及果汁，开拓发糕如何健康有效吃，同时可以说增加了类似保健食品领域，是一种新的品种。
(2)本发明的一种食用可治糖尿病、高血压的发糕对预防和缓解糖尿病、高血压等各种不良反应等具有快速调理作用，临床验证表明本发明的发糕味道可口，保健功能显著，本发明的发糕所达疗效是本领域普通技术人员意想不到的。
(3)本发明的发糕制备工艺简单，配方合理，具有食用方便性、便携性、时尚性，而且能纠正血液流变性异常，降低血糖，是一款高大上的健康保健发糕，具有广大推广价值。
具体实施方式
下面结合具体实施例对本发明进行详细描述，但本发明并不局限于具体实施例。
实施例1
原料：黄芪提取物5份、丹参提取物3份、茯苓提取物5份、玉米须提取物5份、灵芝10份、女贞子30份、麦冬10份、玉竹提取物10份、冬虫夏草60份、山茱萸30份、肉苁蓉提取物15份、香蕉皮提取物15份、木瓜15份、枸杞15份、山楂10份。
制备：
1)称取下述各重量份原料：黄芪提取物5份、丹参提取物3份、茯苓提取物5份、玉米须提取物5份、灵芝10份、女贞子30份、麦冬10份、玉竹提取物10份、冬虫夏草60份、山茱萸30份、肉苁蓉提取物15份、香蕉皮提取物15份、木瓜15份、枸杞15份、山楂10份；
2)将上述灵芝、女贞子、麦冬、冬虫夏草、山茱萸一起加水煎煮二次，第一次加水6倍量，煎煮2小时，第二次加水4倍量，煎煮1小时，合并提取液，滤过，滤液浓缩至相对密度为1.15～1.20，加乙醇至含醇量为70％，搅拌均匀，冷藏静置，滤过，滤液减压回收乙醇至无醇味并浓缩至稠膏；
3)将木瓜、枸杞、山楂混合经榨汁机搅拌，去渣，取果汁备用；
4)取小麦粉，倒入各重量份的黄芪提取物、丹参提取物、茯苓提取物、玉米须提取物、玉竹提取物、肉苁蓉提取物、香蕉皮提取物、步骤2）所得的稠膏和步骤3）所得的果汁，加入适量水经和面机搅拌，放进发酵箱中，设置25～30℃，第一次醒发60-120分钟后，再用和面机搅拌5～10分钟，挤压面团内的气泡，防止成品形成大的空泡，放入发酵箱，设置温度25～30℃，第二次醒发25-40分钟；最后将发酵好的面团直接倒入预先抹好薄油的模具中，与模具一起覆上保鲜膜，直接隔水蒸30-50分钟，出锅后冷却脱模、包装、出厂，即得。
实施例2
原料：黄芪提取物8份、丹参提取物6份、茯苓提取物8份、玉米须提取物8份、灵芝15份、女贞子20份、麦冬10份、玉竹提取物20份、冬虫夏草50份、山茱萸25份、肉苁蓉提取物20份、香蕉皮提取物20份、木瓜15份、枸杞15份、山楂15份。
制备方法同实施例1相同。
实施例3
原料：黄芪提取物3份、丹参提取物2份、茯苓提取物3份、玉米须提取物5份、灵芝10份、女贞子20份、麦冬10份、玉竹提取物10份、冬虫夏草50份、山茱萸20份、肉苁蓉提取物15份、香蕉皮提取物10份、木瓜10份、枸杞10份、山楂10份。
制备方法同实施例1相同。
最后应说明的是：以上仅为本发明的优选实施例而已，并不用于限制本发明，尽管参照实施例对本发明进行了详细的说明，对于本领域的技术人员来说，其依然可以对前述各实施例所记载的技术方案进行修改，或者对其中部分技术特征进行等同替换，但是凡在本发明的精神和原则之内，所作的任何修改、等同替换、改进等，均应包含在本发明的保护范围之内。
Claims (10)
1.一种食用可治糖尿病、高血压的发糕，其特征在于，它是由下述重量份的原料配制而成的：黄芪提取物3~8份、丹参提取物2~6份、茯苓提取物3~8份、玉米须提取物3~8份、灵芝10~20份、女贞子20~40份、麦冬10~20份、玉竹提取物10~20份、冬虫夏草50~80份、山茱萸20~30份、肉苁蓉提取物15~25份、香蕉皮提取物10~20份、木瓜10~20份、枸杞10~20份、山楂10~20份。
2.根据权利要求1所述的一种食用可治糖尿病、高血压的发糕，其特征在于，它是由下述重量份的原料配制成的：黄芪提取物5份、丹参提取物3份、茯苓提取物5份、玉米须提取物5份、灵芝10份、女贞子30份、麦冬10份、玉竹提取物10份、冬虫夏草60份、山茱萸30份、肉苁蓉提取物15份、香蕉皮提取物15份、木瓜15份、枸杞15份、山楂10份。
3.根据权利要求1或2所述的一种食用可治糖尿病、高血压的发糕，其特征在于，所述黄芪提取物是由下述方法制成：称取黄芪，加入所述黄芪质量3倍的体积浓度为75%的乙醇水溶液，置85kHz的超声波清洗仪器中超声4分钟，再加入所述黄芪质量7倍的体积浓度为75%的乙醇水溶液，常压加热回流3小时，滤过，浓缩提取物。
4.根据权利要求1或2所述的一种食用可治糖尿病、高血压的发糕，其特征在于，所述丹参提取物是由下述方法制成：称取丹参，加入所述丹参质量3倍的体积浓度为60%的乙醇水溶液，置85kHz的超声波清洗仪器中超声4分钟，再加入所述丹参质量7倍的体积浓度为60%的乙醇水溶液，常压加热回流3小时，滤过，浓缩提取物。
5.根据权利要求1或2所述的一种食用可治糖尿病、高血压的发糕，其特征在于，所述茯苓提取物是由下述方法制成：称取茯苓，加入所述茯苓质量3倍的体积浓度为60%的乙醇水溶液，置85kHz的超声波清洗仪器中超声4分钟，再加入所述茯苓质量7倍的体积浓度为75%的乙醇水溶液，常压加热回流3小时，滤过，浓缩提取物。
6.根据权利要求1或2所述的一种食用可治糖尿病、高血压的发糕，其特征在于，所述玉米须提取物是由下述方法制成：称取玉米须，加入所述玉米须质量3倍的体积浓度为60%的乙醇水溶液，置85kHz的超声波清洗仪器中超声4分钟，再加入所述玉米须质量7倍的体积浓度为75%的乙醇水溶液，常压加热回流3小时，滤过，浓缩提取物。
7.根据权利要求1或2所述的一种食用可治糖尿病、高血压的发糕，其特征在于，所述玉竹提取物是由下述方法制成：称取玉竹，加入所述玉竹质量3倍的体积浓度为60%的乙醇水溶液，置85kHz的超声波清洗仪器中超声4分钟，再加入所述玉竹质量7倍的体积浓度为60%的乙醇水溶液，常压加热回流3小时，滤过，浓缩提取物。
8.根据权利要求1或2所述的一种食用可治糖尿病、高血压的发糕，其特征在于，所述肉苁蓉提取物是由下述方法制成：称取肉苁蓉，加入所述肉苁蓉质量3倍的体积浓度为65%的乙醇水溶液，置85kHz的超声波清洗仪器中超声4分钟，再加入所述肉苁蓉质量7倍的体积浓度为70%的乙醇水溶液，常压加热回流3小时，滤过，浓缩提取物。
9.根据权利要求1或2所述的一种食用可治糖尿病、高血压的发糕，其特征在于，所述香蕉皮提取物是由下述方法制成：称取香蕉皮，加入所述香蕉皮质量3倍的体积浓度为60%的乙醇水溶液，置85kHz的超声波清洗仪器中超声4分钟，再加入所述香蕉皮质量7倍的体积浓度为60%的乙醇水溶液，常压加热回流3小时，滤过，浓缩提取物。
10.根据权利要求1所述的一种食用可治糖尿病、高血压的发糕的制备方法，其特征在于该方法包括如下步骤：
1）称取下述各重量份原料：黄芪提取物3~8份、丹参提取物2~6份、茯苓提取物3~8份、玉米须提取物3~8份、灵芝10~20份、女贞子20~40份、麦冬10~20份、玉竹提取物10~20份、冬虫夏草50~80份、山茱萸20~30份、肉苁蓉提取物15~25份、香蕉皮提取物10~20份、木瓜10~20份、枸杞10~20份、山楂10~20份；
2）将上述灵芝、女贞子、麦冬、冬虫夏草、山茱萸一起加水煎煮二次，第一次加水6倍量，煎煮2小时，第二次加水4倍量，煎煮1小时，合并提取液，滤过，滤液浓缩至相对密度为1.15～1.20，加乙醇至含醇量为70％，搅拌均匀，冷藏静置，滤过，滤液减压回收乙醇至无醇味并浓缩至稠膏；
3）将木瓜、枸杞、山楂混合经榨汁机搅拌，去渣，取果汁备用；
4）取小麦粉，倒入各重量份的黄芪提取物、丹参提取物、茯苓提取物、玉米须提取物、玉竹提取物、肉苁蓉提取物、香蕉皮提取物、步骤2）所得的稠膏和步骤3）所得的果汁，加入适量水经和面机搅拌，放进发酵箱中，设置25～30℃，第一次醒发60-120分钟后，再用和面机搅拌5～10分钟，挤压面团内的气泡，防止成品形成大的空泡，放入发酵箱，设置温度25～30℃，第二次醒发25-40分钟；最后将发酵好的面团直接倒入预先抹好薄油的模具中，与模具一起覆上保鲜膜，直接隔水蒸30-50分钟，出锅后冷却脱模、包装、出厂，即得。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510917494.4A CN105558788A (zh) | 2015-12-14 | 2015-12-14 | 一种食用可治糖尿病、高血压的发糕及制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510917494.4A CN105558788A (zh) | 2015-12-14 | 2015-12-14 | 一种食用可治糖尿病、高血压的发糕及制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105558788A true CN105558788A (zh) | 2016-05-11 |
Family
ID=55869905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510917494.4A Withdrawn CN105558788A (zh) | 2015-12-14 | 2015-12-14 | 一种食用可治糖尿病、高血压的发糕及制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105558788A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110236098A (zh) * | 2019-07-01 | 2019-09-17 | 中国农业科学院农产品加工研究所 | 营养灵芝多糖发糕及其制备方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103211158A (zh) * | 2013-03-22 | 2013-07-24 | 高雷 | 一种降血压玉米发糕的制作方法 |
| CN104815212A (zh) * | 2015-04-28 | 2015-08-05 | 奚济孝 | 一种治疗婴儿尿布疹的中药药膏及制备方法 |
-
2015
- 2015-12-14 CN CN201510917494.4A patent/CN105558788A/zh not_active Withdrawn
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103211158A (zh) * | 2013-03-22 | 2013-07-24 | 高雷 | 一种降血压玉米发糕的制作方法 |
| CN104815212A (zh) * | 2015-04-28 | 2015-08-05 | 奚济孝 | 一种治疗婴儿尿布疹的中药药膏及制备方法 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110236098A (zh) * | 2019-07-01 | 2019-09-17 | 中国农业科学院农产品加工研究所 | 营养灵芝多糖发糕及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101695376B (zh) | 预防糖尿病的保健食品 | |
| CN104719535A (zh) | 一种改善女性亚健康状态的玛卡黑茶组合物及制备方法 | |
| CN104304611A (zh) | 一种保健山楂糕及其制备方法 | |
| CN105475787A (zh) | 一种石斛麦冬乳饮料及其制备方法 | |
| CN108524814A (zh) | 一种用于降低血糖的中药组合物及其制备方法 | |
| CN1452875A (zh) | 一种以红景天、灵芝为主料的保健茶及其制备方法 | |
| CN108991215A (zh) | 一种滇橄榄果脯及其制备方法 | |
| KR20210001439A (ko) | 누룩발효공법을 이용한 건강식품 조성물과 그 제조방법 | |
| CN110122803A (zh) | 一种诺丽果片及其制备方法 | |
| CN104719536A (zh) | 一种改善男性亚健康状态的玛卡黑茶组合物及制备方法 | |
| KR20130104692A (ko) | 산사육 추출물을 함유하는 비만치료 및 예방용 조성물 | |
| CN105249369A (zh) | 一种橡子刺梨槐花果酱的制作方法 | |
| CN105124078A (zh) | 一种栀子花降糖降脂保健茶及其制备方法 | |
| KR20180026674A (ko) | 삼백초가 포함된 약선음료 및 이의 제조방법 | |
| KR100853829B1 (ko) | 고혈압 예방 및 지질대사 개선용 기능성 간장 및 그 제조방법 | |
| CN110051815A (zh) | 一种辅助降血糖食丸及其制备方法 | |
| CN103478560B (zh) | 一种用牛奶和绞股蓝制造的营养大米 | |
| CN104818173A (zh) | 一种防治高血脂的保健葡萄酒及其制作方法 | |
| KR102070507B1 (ko) | 흑삼 삼계탕의 제조방법 및 이에 의해 제조된 흑삼 삼계탕 | |
| CN105558788A (zh) | 一种食用可治糖尿病、高血压的发糕及制备方法 | |
| CN104544084A (zh) | 一种用于糖尿病患者的保健食品 | |
| CN108783432A (zh) | 具有抗癌作用的保健食品及其制备方法 | |
| CN100396189C (zh) | 养肝降脂果丹食品 | |
| CN105733885A (zh) | 一种沙苑子酒的生物发酵酿造方法 | |
| CN105394279A (zh) | 一种添加中药的降脂减肥茶及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160511 |
|
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Wang Jinguo Document name: Notification of Approving Refund |